Sanctuary Advisors LLC Trims Stock Holdings in Select Medical Holdings Co. (NYSE:SEM)

Sanctuary Advisors LLC lowered its position in shares of Select Medical Holdings Co. (NYSE:SEMFree Report) by 6.4% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 23,416 shares of the health services provider’s stock after selling 1,607 shares during the quarter. Sanctuary Advisors LLC’s holdings in Select Medical were worth $817,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently modified their holdings of SEM. Dimensional Fund Advisors LP boosted its stake in Select Medical by 2.2% during the second quarter. Dimensional Fund Advisors LP now owns 4,498,772 shares of the health services provider’s stock worth $157,728,000 after acquiring an additional 95,578 shares in the last quarter. Geode Capital Management LLC grew its stake in shares of Select Medical by 2.0% in the 3rd quarter. Geode Capital Management LLC now owns 2,442,321 shares of the health services provider’s stock worth $85,180,000 after buying an additional 46,880 shares during the last quarter. Principal Financial Group Inc. increased its position in Select Medical by 6.7% during the 3rd quarter. Principal Financial Group Inc. now owns 2,357,823 shares of the health services provider’s stock valued at $82,208,000 after buying an additional 147,032 shares in the last quarter. Point72 Asset Management L.P. raised its stake in Select Medical by 144.2% during the third quarter. Point72 Asset Management L.P. now owns 2,059,791 shares of the health services provider’s stock valued at $71,825,000 after buying an additional 1,216,263 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its holdings in Select Medical by 1.5% in the third quarter. Charles Schwab Investment Management Inc. now owns 1,646,320 shares of the health services provider’s stock worth $57,407,000 after acquiring an additional 24,439 shares in the last quarter. 89.48% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at Select Medical

In other news, Director Marilyn B. Tavenner sold 32,000 shares of the company’s stock in a transaction on Tuesday, November 26th. The stock was sold at an average price of $21.09, for a total value of $674,880.00. Following the completion of the sale, the director now directly owns 22,000 shares in the company, valued at $463,980. This represents a 59.26 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, VP Robert G. Breighner, Jr. sold 4,989 shares of Select Medical stock in a transaction on Wednesday, December 4th. The shares were sold at an average price of $19.95, for a total value of $99,530.55. Following the transaction, the vice president now owns 30,356 shares in the company, valued at $605,602.20. This trade represents a 14.12 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 19.14% of the stock is owned by corporate insiders.

Analyst Ratings Changes

Several research analysts have issued reports on the stock. Royal Bank of Canada lifted their target price on shares of Select Medical from $40.00 to $47.00 and gave the stock an “outperform” rating in a report on Monday, November 4th. Benchmark downgraded shares of Select Medical from a “buy” rating to a “hold” rating in a research report on Monday, November 25th. Finally, StockNews.com raised Select Medical from a “hold” rating to a “buy” rating in a research report on Tuesday, December 3rd.

Read Our Latest Stock Report on SEM

Select Medical Stock Performance

Shares of NYSE SEM opened at $19.04 on Tuesday. The company has a quick ratio of 1.13, a current ratio of 1.13 and a debt-to-equity ratio of 1.37. The firm’s 50-day moving average price is $29.49 and its 200-day moving average price is $33.12. Select Medical Holdings Co. has a 52-week low of $18.02 and a 52-week high of $40.98. The company has a market cap of $2.47 billion, a PE ratio of 8.90, a PEG ratio of 0.39 and a beta of 1.43.

Select Medical (NYSE:SEMGet Free Report) last released its quarterly earnings results on Thursday, October 31st. The health services provider reported $0.43 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.36 by $0.07. The firm had revenue of $1.76 billion for the quarter, compared to the consensus estimate of $1.74 billion. Select Medical had a return on equity of 15.99% and a net margin of 3.97%. The company’s revenue for the quarter was up 5.7% on a year-over-year basis. During the same period last year, the business posted $0.46 EPS. As a group, analysts anticipate that Select Medical Holdings Co. will post 1.97 EPS for the current year.

Select Medical Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, November 26th. Investors of record on Wednesday, November 13th were given a dividend of $0.125 per share. The ex-dividend date was Wednesday, November 13th. This represents a $0.50 annualized dividend and a yield of 2.63%. Select Medical’s dividend payout ratio (DPR) is 23.36%.

Select Medical Profile

(Free Report)

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.

Read More

Want to see what other hedge funds are holding SEM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Select Medical Holdings Co. (NYSE:SEMFree Report).

Institutional Ownership by Quarter for Select Medical (NYSE:SEM)

Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.